2026 the Japanese Society of Medical Oncology Annual Meeting - JSMO2026 YOKOHAMA
Our Invited Speakers and Chairs（as of January 08）
James LynamMOGA; Department of Medical Oncology, Calvary Mater Hospital NewcastleAustraliaEls Van NieuwenhuysenUniversity Hospital Leuven – Belgium KU LeuvenBelguimAya El HelaliThe University of Hong KongChinaTony SK MokThe Chinese University of Hong KongChinaChangsong QiDepartment of Early Drug Development Centre, Peking University Cancer Hospital & InstituteChinaLu ShunShanghai Chest HospitalChinaFabrice AndréESMO President; Gustave RoussyFranceEtienne ChatelutOncopole Claudius-Regaud, University of ToulouseFranceMaria Fernanda MoseleInstitute Gustave RoussyFranceChristophe Le TourneauGustave RoussyFranceSylvie LorenzenTechnische Universität MünchenGermanyNiels ReinmuthAsklepios Lungenklinik GautingGermanyGiuseppe CuriglianoUniversity of Milano and European Institute of Oncology, Milano,ItalyByoung Chul ChoYonsei Cancer Center, Yonsei University College of MedicineKoreaSeock-Ah ImSeoul National UniversityKoreaHyehyun JeongAsan Medical CenterKoreaBhumsuk KeamSeoul National University HospitalKoreaJae-Weon KimSeoul National University HospitalKoreaSung-Bae KimDepartment of Oncology, Asan Medical Center; University of Ulsan College of MedicineKoreaYeon Hee ParkSamsung Medical Center; Sungkyunkwan University School of MedicineKoreaSun Young RhaYonsei University College of MedicineKoreaChanghoon YooDepartment of Oncology, Asan Medical Center, University of Ulsan College of MedicineKoreaPei Jye VoonSarawak General HospitalMalaysiaMyriam ChalabiMedical Oncologist. Department of Gastrointestinal Oncology, Netherlands Cancer InstituteNetherlandsRavindran KanesvaranSSO President; National Cancer Centre SingaporeSingaporeTira J. TanNational Cancer Centre SingaporeSingaporeYoon Sim YapNational Cancer Centre SingaporeSingaporeDavid Shao-Peng TanNational University Health SystemSingaporeTeresa MacarullaGastrointestinal and Endocrine Tumor Unit, Vall d'Hebron University Hospital and Vall d'Hebron Institute of OncologySpainMing-Huang ChenTaipei Veterans General HospitalTaiwanChih-Hung HsuNational Taiwan UniversityTaiwanYen-Shen LuNational Taiwan University HospitalTaiwanJames Chih-Hsin YangNational Taiwan University Cancer Center HospitalTaiwanThanachai SanlungKhon Kaen UniviersityThailandThomas B. PowlesBarts Cancer Institute, Queen Mary University of LondonUKAlexander BagaevChief Product Officer (CPO), BostonGene CorporationUSAJorge E. CortesGeorgia Cancer CenterUSAWilliam DaleGeorgia Cancer CenterUSAAlexey V. DanilovMarianne and Gerhard Pinkus Professor in Early Clinical Therapeutics, City of Hope National Medical CenterUSANaval DaverDirector, Leukemia Research Alliance Program, Professor of Medicine Department of Leukemia MD Anderson Cancer CenterUSAHamid EmamekhooUniversity of Wisconsin MadisonUSAErika P. HamiltonSarah Cannon Research InstituteUSARobin Katie KelleyUniversity of California, San FranciscoUSAKah Poh LohUniversity of Rochester Medical CenterUSAErica L. MayersDana-Farber Cancer InstituteUSAHope S. RugoDivision Chief, Breast Medical Oncology, City of Hope Cancer CenterUSAQian ShiDepartment of Quantitative Health Sciences, Mayo ClinicUSACardinale B. SmithChief Medical Officer, MSKCCUSARaghav SundarYale University School of Medicine and Yale Cancer CenterUSASandra M. SwainGeorgetown University Medical CenterUSARobin T. ZonASCOUSA
